Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL Step: Tofacitinib in RA with Inadequate Response to TNF Inhibitors
NCT00960440Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Oct 2009; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00960440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960440.